CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 20 8089 7893 support@capital.com

Perdagangan Collegium Pharmaceutical - COLL CFD

17.74
2.37%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.08
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.030779%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.013666%
Waktu biaya inap 22:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 18.11
Open* 17.99
1-Year Change* 1.35%
Day's Range* 17.32 - 17.99
52 wk Range 14.04-30.22
Average Volume (10 days) 348.12K
Average Volume (3 months) 6.72M
Market Cap 984.33M
P/E Ratio -100.00K
Shares Outstanding 33.57M
Revenue 361.68M
EPS -1.26
Dividend (Yield %) N/A
Beta 0.80
Next Earnings Date Feb 22, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 29, 2022 17.74 -0.24 -1.33% 17.98 18.10 17.27
Jun 28, 2022 18.11 -0.64 -3.41% 18.75 19.23 18.03
Jun 27, 2022 18.75 1.05 5.93% 17.70 19.17 17.70
Jun 24, 2022 18.26 1.02 5.92% 17.24 18.27 17.05
Jun 23, 2022 17.24 0.61 3.67% 16.63 17.26 16.62
Jun 22, 2022 16.95 1.07 6.74% 15.88 17.46 15.88
Jun 21, 2022 15.97 0.36 2.31% 15.61 16.12 15.61
Jun 17, 2022 15.78 0.32 2.07% 15.46 15.94 15.30
Jun 16, 2022 15.55 0.41 2.71% 15.14 15.81 15.12
Jun 15, 2022 16.09 0.94 6.20% 15.15 16.40 15.15
Jun 14, 2022 15.62 0.42 2.76% 15.20 15.68 15.16
Jun 13, 2022 15.42 -0.31 -1.97% 15.73 15.89 15.03
Jun 10, 2022 16.16 0.12 0.75% 16.04 16.50 15.99
Jun 9, 2022 16.42 0.59 3.73% 15.83 16.54 15.83
Jun 8, 2022 16.18 0.35 2.21% 15.83 16.23 15.82
Jun 7, 2022 15.91 0.33 2.12% 15.58 15.93 15.55
Jun 6, 2022 15.69 0.08 0.51% 15.61 15.85 15.58
Jun 3, 2022 15.61 0.02 0.13% 15.59 15.71 15.40
Jun 2, 2022 15.64 0.16 1.03% 15.48 15.83 15.01
Jun 1, 2022 15.46 -0.16 -1.02% 15.62 15.74 14.80

Collegium Pharmaceutical Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 1.711 28.476 280.413 296.701 310.016 276.868
Revenue 1.711 28.476 280.413 296.701 310.016 276.868
Cost of Revenue, Total 0.213 2.595 165.677 193.66 130.18 126.251
Gross Profit 1.498 25.881 114.736 103.041 179.836 150.617
Total Operating Expense 95.793 103.923 301.098 320.449 253.784 259.24
Selling/General/Admin. Expenses, Total 80.632 90.911 126.76 116.449 113.832 116.025
Research & Development 14.948 8.572 8.661 10.34 9.772 9.451
Unusual Expense (Income) 0 1.845 7.513
Operating Income -94.082 -75.447 -20.685 -23.748 56.232 17.628
Interest Income (Expense), Net Non-Operating -0.094 0.582 -18.443 1.026 -28.65 -21.002
Net Income Before Taxes -94.176 -74.865 -39.128 -22.722 27.582 -3.374
Net Income After Taxes -94.176 -74.865 -39.128 -22.722 26.752 71.517
Net Income Before Extra. Items -94.176 -74.865 -39.128 -22.722 26.752 71.517
Net Income -94.176 -74.865 -39.128 -22.722 26.752 71.517
Total Adjustments to Net Income 0
Income Available to Common Excl. Extra. Items -94.176 -74.865 -39.128 -22.722 26.752 71.517
Income Available to Common Incl. Extra. Items -94.176 -74.865 -39.128 -22.722 26.752 71.517
Diluted Net Income -94.176 -74.865 -39.128 -22.722 26.752 76.192
Diluted Weighted Average Shares 24.263 30.2653 32.9538 33.4538 35.1513 41.0458
Diluted EPS Excluding Extraordinary Items -3.88147 -2.47363 -1.18736 -0.6792 0.76105 1.85627
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -3.88147 -2.41267 -1.18736 -0.6792 0.76105 1.97524
Dilution Adjustment 4.675
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 87.721 82.942 78.843 27.362 83.751
Revenue 87.721 82.942 78.843 27.362 83.751
Cost of Revenue, Total 32.123 32.703 32.73 28.695 35.255
Gross Profit 55.598 50.239 46.113 -1.333 48.496
Total Operating Expense 66.529 66.533 64.694 61.484 93.766
Selling/General/Admin. Expenses, Total 31.476 30.368 30.514 26.602 54.528
Research & Development 2.93 3.462 1.45 1.609 3.983
Operating Income 21.192 16.409 14.149 -34.122 -10.015
Interest Income (Expense), Net Non-Operating -5.718 -5.418 -5.112 -4.754 -5.827
Net Income Before Taxes 15.474 10.991 9.037 -38.876 -15.842
Net Income After Taxes 15.662 72.843 8.046 -25.034 -13.069
Net Income Before Extra. Items 15.662 72.843 8.046 -25.034 -13.069
Net Income 15.662 72.843 8.046 -25.034 -13.069
Income Available to Common Excl. Extra. Items 15.662 72.843 8.046 -25.034 -13.069
Income Available to Common Incl. Extra. Items 15.662 72.843 8.046 -25.034 -13.069
Dilution Adjustment 1.165 1.168 1.171
Diluted Net Income 16.827 74.011 9.217 -25.034 -13.069
Diluted Weighted Average Shares 41.1601 41.2868 36.2612 34.1144 33.6739
Diluted EPS Excluding Extraordinary Items 0.40882 1.7926 0.25418 -0.73383 -0.3881
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.40882 1.7926 0.25418 -0.6466 -0.3881
Unusual Expense (Income) 4.578
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 158.575 133.484 237.512 255.72 277.888 315.543
Cash and Short Term Investments 153.225 118.697 146.633 170.019 174.116 186.426
Cash & Equivalents 153.225 118.697 146.633 170.019 174.116 186.426
Total Receivables, Net 2.129 9.969 77.946 72.953 83.32 105.844
Accounts Receivable - Trade, Net 2.129 9.969 77.946 72.953 83.32 105.844
Total Inventory 1.316 1.813 7.817 9.643 15.614 17.394
Prepaid Expenses 1.601 2.549 4.108 2.964 4.778 5.852
Other Current Assets, Total 0.304 0.456 1.008 0.141 0.06 0.027
Total Assets 162.017 135.568 291.245 306.302 643.841 692.077
Property/Plant/Equipment, Total - Net 1.038 1.826 9.274 20.901 27.379 27.135
Property/Plant/Equipment, Total - Gross 2.37 3.494 11.111 23.189 30.435 31.831
Accumulated Depreciation, Total -1.332 -1.668 -1.837 -2.288 -3.056 -4.696
Intangibles, Net 2.103 0 44.255 29.503 335.904 268.723
Other Long Term Assets, Total 0.301 0.258 0.204 0.178 2.67 80.676
Total Current Liabilities 25.596 31.488 189.126 201.765 239.451 279.566
Accounts Payable 9.106 5.684 12.15 6.247 10.016 4.189
Accrued Expenses 8.879 24.325 175.334 191.685 180.123 223.832
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2.667 1.479 1.642 3.833 47.495 48.353
Other Current Liabilities, Total 4.944 0 1.817 3.192
Total Liabilities 27.109 31.488 199.66 218.87 457.81 489.149
Total Long Term Debt 1.513 0 9.858 7.667 209.594 201.632
Long Term Debt 1.479 0 9.858 7.667 209.594 201.632
Capital Lease Obligations 0.034 0
Total Equity 134.908 104.08 91.585 87.432 186.031 202.928
Common Stock 0.029 0.033 0.033 0.034 0.035 0.036
Additional Paid-In Capital 358.063 402.096 428.729 447.297 519.143 502.095
Retained Earnings (Accumulated Deficit) -223.184 -298.049 -337.177 -359.899 -333.147 -256.342
Treasury Stock - Common 0 -42.861
Total Liabilities & Shareholders’ Equity 162.017 135.568 291.245 306.302 643.841 692.077
Total Common Shares Outstanding 29.3641 32.7707 33.2656 33.6788 34.612 33.6554
Other Liabilities, Total 0.676 9.438 8.765 7.951
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 296.311 318.532 363.238 315.543 363.638
Cash and Short Term Investments 182.79 202.771 193.241 186.426 106.698
Cash & Equivalents 182.79 202.771 193.241 186.426 106.698
Total Receivables, Net 93.156 90.098 148.999 105.844 166.345
Accounts Receivable - Trade, Net 93.156 90.098 148.999 105.844 166.345
Total Inventory 15.498 19.595 17.358 17.394 80.146
Prepaid Expenses 4.867 6.068 3.64 5.879 10.449
Total Assets 646.065 713.735 741.803 692.077 1246.14
Property/Plant/Equipment, Total - Net 27.969 27.578 27.464 27.135 28.014
Intangibles, Net 319.109 302.314 285.518 268.723 694.799
Other Long Term Assets, Total 2.676 65.311 65.583 80.676 28.178
Total Current Liabilities 230.168 226.843 268.973 279.566 373.573
Accounts Payable 8.666 7.543 7.73 4.189 3.851
Accrued Expenses 171.746 171.277 210.677 223.832 264.577
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 47.705 47.919 48.135 48.353 100
Other Current Liabilities, Total 2.051 0.104 2.431 3.192 5.145
Total Liabilities 476.03 460.669 490.709 489.149 1050.06
Total Long Term Debt 237.292 225.455 213.57 201.632 668.579
Long Term Debt 237.292 225.455 213.57 201.632 668.579
Other Liabilities, Total 8.57 8.371 8.166 7.951 7.913
Total Equity 170.035 253.066 251.094 202.928 196.076
Common Stock 0.035 0.036 0.036 0.036 0.036
Additional Paid-In Capital 482.197 492.384 499.846 502.095 513.312
Retained Earnings (Accumulated Deficit) -312.197 -239.354 -231.308 -256.342 -269.411
Total Liabilities & Shareholders’ Equity 646.065 713.735 741.803 692.077 1246.14
Total Common Shares Outstanding 35.2038 35.5239 34.7971 33.6554 33.9231
Treasury Stock - Common -17.48 -42.861 -47.861
Goodwill, Net 131.512
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -94.176 -74.865 -39.128 -22.722 26.752 71.517
Cash From Operating Activities -75.053 -67.018 169.39 27.783 93.942 103.557
Cash From Operating Activities 0.655 0.594 1.074 0.731 0.87 1.736
Non-Cash Items 5.753 9.756 33.059 16.841 30.939 27.679
Cash Interest Paid 0.284 0.139 0.582 0.709 18.967 17.608
Changes in Working Capital 12.715 -2.503 64.551 18.181 -25.299 13.486
Cash From Investing Activities -2.977 -0.99 -24.354 -6.438 -373.772 -1.944
Capital Expenditures -2.977 -0.99 -24.354 -6.438 -373.772 -1.944
Cash From Financing Activities 135.558 33.48 -117.197 2.041 286.474 -89.303
Financing Cash Flow Items 0 -0.068 -132.59 -0.822 -2.255 -4.149
Issuance (Retirement) of Stock, Net 138.225 36.215 5.372 2.863 7.335 -35.154
Issuance (Retirement) of Debt, Net -2.667 -2.667 10.021 0 281.394 -50
Net Change in Cash 57.528 -34.528 27.839 23.386 6.644 12.31
Amortization 109.834 14.752 60.68 67.181
Cash Taxes Paid 0.483 3.005
Deferred Taxes -78.042
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 15.662 88.505 96.551 71.517 -13.069
Cash From Operating Activities 20.57 50.105 67.359 103.557 -25.315
Cash From Operating Activities 0.439 0.864 1.312 1.736 0.715
Amortization 16.795 33.59 50.386 67.181 18.923
Non-Cash Items 7.805 15.205 21.99 27.679 7.206
Cash Taxes Paid 0.418 0.876 2.329 3.005 2.114
Cash Interest Paid 5.746 9.348 14.573 17.608 5.833
Changes in Working Capital -20.131 -25.41 -39.854 13.486 -33.052
Cash From Investing Activities -0.428 -1.153 -1.429 -1.944 -572.177
Capital Expenditures -0.428 -1.153 -1.429 -1.944 -572.177
Cash From Financing Activities -11.468 -20.297 -46.805 -89.303 517.764
Financing Cash Flow Items -3.508 -3.929 -4.149 -4.149 -3.382
Issuance (Retirement) of Stock, Net 4.54 8.632 -5.156 -35.154 3.464
Issuance (Retirement) of Debt, Net -12.5 -25 -37.5 -50 517.682
Net Change in Cash 8.674 28.655 19.125 12.31 -79.728
Deferred Taxes -62.649 -63.026 -78.042 -6.038
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 15.5818 5231124 42870 2022-09-30 LOW
Rubric Capital Management LP Hedge Fund 9.9298 3333628 75000 2022-09-30 MED
Eventide Asset Management, LLC Investment Advisor 7.8327 2629593 0 2022-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 6.822 2290287 25801 2022-09-30 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 5.7071 1915998 -71497 2022-09-30 LOW
Principal Global Investors (Equity) Investment Advisor 5.2502 1762600 24309 2022-09-30 LOW
Emerald Advisers LLC Investment Advisor 4.5054 1512542 -7775 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.0589 1362662 -28031 2022-09-30 LOW
Renaissance Technologies LLC Hedge Fund 3.696 1240818 -156000 2022-09-30 HIGH
Camber Capital Management LP Hedge Fund 3.1276 1050000 0 2022-09-30 MED
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 2.5328 850314 30807 2022-09-30 LOW
MFS Investment Management Investment Advisor/Hedge Fund 2.4334 816926 -53380 2022-09-30 LOW
Invesco Advisers, Inc. Investment Advisor 2.3699 795623 16661 2022-09-30 LOW
Rock Springs Capital Management LP Hedge Fund 2.1595 725000 0 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8042 605692 2306 2022-09-30 LOW
Peregrine Capital Management, LLC Investment Advisor 1.6126 541392 -5889 2022-12-31 LOW
Millennium Management LLC Hedge Fund 1.399 469675 457604 2022-09-30 HIGH
Mesirow Institutional Investment Management, Inc. Investment Advisor/Hedge Fund 1.133 380365 380365 2022-09-30
Pacer Advisors, Inc. Investment Advisor 1.0341 347173 45864 2023-01-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.9784 328455 1402 2022-09-30 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
+485000+

Trader

65000+

Klien aktif per bulan

$48000000+

Volume investasi per bulan

$28000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Pharmaceuticals (NEC)

100 Technology Center Dr
STOUGHTON
MASSACHUSETTS 02072-4710
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,661.40 Price
+0.280% 1D Chg, %
Biaya inap posisi Long -0.0180%
Biaya inap posisi short 0.0070%
Waktu biaya inap 22:00 (UTC)
Spread 1.8

Oil - Crude

74.01 Price
-2.630% 1D Chg, %
Biaya inap posisi Long -0.0216%
Biaya inap posisi short 0.0063%
Waktu biaya inap 22:00 (UTC)
Spread 0.03

Natural Gas

2.40 Price
-2.640% 1D Chg, %
Biaya inap posisi Long -0.1145%
Biaya inap posisi short 0.0801%
Waktu biaya inap 22:00 (UTC)
Spread 0.005

XRP/USD

0.41 Price
-0.370% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 0.00341

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 485.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda